Mahamaya Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 17.77 Cr
as on 15-11-2024
- Company Age 22 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 85.19 Cr
as on 15-11-2024
- Satisfied Charges ₹ 60.64 Cr
as on 15-11-2024
- Revenue 52.50%
(FY 2023)
- Profit 33.00%
(FY 2023)
- Ebitda 46.68%
(FY 2023)
- Net Worth 23.33%
(FY 2023)
- Total Assets 39.64%
(FY 2023)
About Mahamaya Lifesciences
The Corporate was formerly known as Mahamaya Life Sciences Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 17.77 Cr.
The company currently has active open charges totaling ₹85.19 Cr. The company has closed loans amounting to ₹60.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mahamaya Lifesciences Private Limited India is Prashant Krishnamurthy as CFO. Krishnamurthy Ganesan, Lalitha Krishnamurthy, and Prashant Krishnamurthy serve as directors at the Company.
- CIN/LLPIN
U24233DL2002PTC115261
- Company No.
115261
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2002
- Date of AGM
20 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mahamaya Lifesciences Private Limited offer?
Mahamaya Lifesciences Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Non Selective Herbicide, Architectural & Civil Engineering, Architectural Services.
Who are the key members and board of directors at Mahamaya Lifesciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnamurthy Ganesan  | Managing Director | 07-May-2002 | Current |
| Prashant Krishnamurthy | CFO | 25-Oct-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lalitha Krishnamurthy | Whole-Time Director | 07-May-2002 | Current |
| Prashant Krishnamurthy | Director | 25-Aug-2014 | Current |
Financial Performance of Mahamaya Lifesciences.
Mahamaya Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.5% increase. The company also saw a substantial improvement in profitability, with a 33% increase in profit. The company's net worth Soared by an impressive increase of 23.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahamaya Lifesciences?
In 2023, Mahamaya Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 16 Apr 2024 | ₹2.90 M | Open |
Others Creation Date: 11 Mar 2024 | ₹25.00 Cr | Open |
Others Creation Date: 24 Jan 2024 | ₹5.00 Cr | Open |
How Many Employees Work at Mahamaya Lifesciences?
Mahamaya Lifesciences has a workforce of 40 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahamaya Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahamaya Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
